What Are Dividend Aristocrats?
Dividend Aristocrats are S&P 500 companies that have increased their dividends for 25+ consecutive years. As of 2026, there are 67 Aristocrats.
🏆 The Aristocrat Requirements
- Must be in the S&P 500 (large-cap U.S. companies only)
- Must have 25+ consecutive years of dividend increases (not just payments)
- Must meet S&P's financial viability criteria (no imminent bankruptcy)
Why Aristocrats Outperform
Research by S&P Dow Jones Indices shows Aristocrats have outperformed the S&P 500 in total return with lower volatility over most 10-year periods.
| Metric | Aristocrats (1969-2025) | S&P 500 (1969-2025) |
|---|---|---|
| Annualized Return | ~11.2% | ~10.1% |
| Volatility (Std Dev) | ~14.5% | ~18.2% |
| Max Drawdown | ~-34% | ~-51% (2008-2009) |
| Dividend Growth | ~7.2%/year | ~5.8%/year (broader index) |
Complete 2026 Dividend Aristocrats List
🏭 Consumer Staples (16 companies)
- Procter & Gamble (PG) —67 years —Yield: 2.3% —10-yr avg growth: 4.1%
- Coca-Cola (KO) —61 years —Yield: 3.1% —10-yr avg growth: 3.8%
- Colgate-Palmolive (CL) —60 years —Yield: 2.1% —10-yr avg growth: 2.9%
- Walmart (WMT) —49 years —Yield: 1.4% —10-yr avg growth: 2.2%
- Costco (COST) —18 years* —Yield: 0.6% —10-yr avg growth: 12.5%
- ...and 11 more (TGT, KR, ADM, etc.)
💊 Healthcare (13 companies)
- Johnson & Johnson (JNJ) —61 years —Yield: 3.0% —10-yr avg growth: 6.2%
- Pfizer (PFE) —15 years* —Yield: 5.8% —10-yr avg growth: 0.5%
- AbbVie (ABBV) —11 years* —Yield: 3.9% —10-yr avg growth: 18.2%
- ...and 10 more (MRK, BAX, BDX, etc.)
🏦 Financials (12 companies)
- JPMorgan Chase (JPM) —12 years* —Yield: 2.1% —10-yr avg growth: 25.1%
- Bank of America (BAC) —10 years* —Yield: 3.4% —10-yr avg growth: 15.8%
- ...and 10 more (USB, TFC, FITB, etc.)
🏭 Industrials (14 companies)
- 3M Company (MMM) —64 years —Yield: 6.2% —10-yr avg growth: -2.1% ⚠️ (recent cut)
- Caterpillar (CAT) —30 years —Yield: 1.6% —10-yr avg growth: 8.9%
- ...and 12 more (EMR, ITW, GWW, etc.)
🔌 Utilities & Energy (12 companies)
- NextEra Energy (NEE) —28 years —Yield: 2.8% —10-yr avg growth: 8.1%
- ExxonMobil (XOM) —40 years —Yield: 3.2% —10-yr avg growth: 1.8%
- ...and 10 more (DUK, SO, CVX, etc.)
* = joined Aristocrats more recently (after 2000)
How to Invest in Aristocrats
Option 1: Buy Individual Stocks
Requires $50,000+ to diversify across 15-20 Aristocrats. Benefits:
- ✔Pick your favorites (e.g., only consumer staples)
- ✔Tax-loss harvesting opportunities
- ✔Control over exact allocation
- ❌Requires more time and research
- ❌High minimum investment for diversification
Option 2: NOBL ETF (ProShares S&P 500 Dividend Aristocrats ETF)
NOBL holds all 67 Aristocrats in a single ETF:
- ✔0.35% expense ratio —reasonable for 67 holdings
- ✔Automatic rebalancing when companies are added/removed
- ✔Diversification across all 11 sectors
- ❌You can't exclude recent underperformers (e.g., MMM after dividend cut)
Option 3: VIG ETF (Vanguard Dividend Appreciation ETF)
VIG focuses on companies with 10+ years of dividend growth (broader than Aristocrats):
- ✔0.06% expense ratio —much cheaper than NOBL
- ✔~400 holdings (more diversified than NOBL's 67)
- ✔Includes some mid-cap dividend growers
- ❌Less focused on the "premium" 25-year track record
Which Aristocrats Have the Best Long-Term Performance?
🏆 Top 5 Aristocrats by 10-Year Total Return (2016-2026)
- Home Depot (HD) —~18.2%/year (but was removed from Aristocrats in 2023 due to dividend freeze)
- Lowe's (LOW) —~15.8%/year
- AbbVie (ABBV) —~14.5%/year
- Mastercard (MA) —~22.1%/year (but yield is only 0.5% —not a high-income play)
- Visa (V) —~17.8%/year (also low yield ~0.8%)
Key insight: The best total return Aristocrats often have low current yields (0.5-2%). If you need current income, focus on higher-yield Aristocrats like XOM (3.2%), KO (3.1%), or CL (2.1%).
Companies Close to Joining Aristocrats (2027–2030)
Several high-quality S&P 500 companies are approaching the 25-year milestone and may join the Aristocrats list soon. These "near-Aristocrats" are worth watching:
📈 Potential Future Aristocrats
- Microsoft (MSFT) —22 years of increases (will join ~2029) —Yield: 0.8% —Strong balance sheet
- Apple (AAPL) —12 years of increases —Yield: 0.5% —Massive cash reserves
- Visa (V) —18 years of increases —Yield: 0.8% —Pricing power moat
- Mastercard (MA) —16 years of increases —Yield: 0.6% —Similar moat to Visa
Strategy: Buying near-Aristocrats early gives you exposure to companies with Aristocrat-like discipline but lower current valuations.
Risks of Investing in Aristocrats
⚠️ Risk 1: Dividend Cuts Can Happen
Even Aristocrats can cut dividends during severe crises. 3M (MMM) cut its dividend in 2024 after 64 years of increases. Always monitor payout ratios.
⚠️ Risk 2: Sector Concentration
Aristocrats are heavily weighted toward consumer staples, industrials, and healthcare. You'll have little exposure to technology or communication services.
⚠️ Risk 3: Interest Rate Sensitivity
Many Aristocrats (utilities, REITs, consumer staples) decline when interest rates rise, as investors shift to bonds.
How to Use Our Dividend Aristocrat Calculator
Visit our Dividend Aristocrat Growth Calculator to model:
- How a 2.5% yield growing at 7%/year compounds over 20 years
- Comparison vs. a high-yield (6%) stock with 2% growth
- DRIP vs. no-DRIP scenarios
ETF vs. Individual Aristocrats: Which to Pick
- NOBL (ProShares S&P 500 Dividend Aristocrats ETF): Holds the full Aristocrats index, ~0.35% expense ratio. Instant diversification, no single-stock risk, automatic rebalancing when companies are added/removed.
- VIG (Vanguard Dividend Appreciation ETF): Broader "dividend growers" mandate, ~0.06% expense ratio, lower yield (~1.9%) but very low cost.
- Individual stocks: Higher potential yield and tax control (you choose lots), but require monitoring payout ratios and concentration. Best for investors who enjoy research.
For most people, a core position in NOBL or VIG plus a few hand-picked high-quality names (KO, PG, JNJ) balances cost, diversification, and yield.
Rebalancing an Aristocrat Portfolio
Because Aristocrats are concentrated in staples, healthcare, and industrials, add broad-market exposure (an S&P 500 index) so you're not overexposed to one corner of the market. Rebalance annually: if a holding's weight drifts more than ~5% from target, trim and redeploy. A dividend-grower portfolio should still be checked for valuation — a 2% yield that has run up 40% may be less attractive than it was.
Bottom Line
Aristocrats are a quality screen, not a guarantee. They reduce — but don't eliminate — dividend-cut risk, and they trade growth for stability. Use the Aristocrat Growth Calculator to see how a 25-year grower compounds, and keep the yield vs. payout-ratio distinction in mind before buying.
Related Articles:
What Is Dividend Yield?
DRIP vs. Manual Reinvestment
External Resources: S&P Dow Jones Indices Aristocrats Page | SEC Dividend Investor Bulletin
ETF vs. Individual Aristocrats — Which to Use
You can own Aristocrats two ways: buy the individual stocks, or buy an index ETF that holds them. Each has trade-offs:
| Individual Stocks | ETF (e.g., VIG, SCHD, NOBL) | |
|---|---|---|
| Effort | High — track 20–50 names | Low — one purchase |
| Diversification | Lower, concentration risk | Higher, instantly spread |
| Fees | Possible commissions | ~0.06%–0.10% expense ratio |
| Control | Full | None (fund decides) |
Most beginners are better served by an ETF like SCHD (Schwab U.S. Dividend Equity) or VIG (Vanguard Dividend Appreciation); hands-on investors add individual names such as Coca-Cola (KO) or PepsiCo (PEP) on top.
How to Build an Aristocrat-Focused Portfolio
A reasonable structure: 60% core dividend-growth ETF (VIG/SCHD), 20% in 5–8 individual Aristocrats you actually understand, and 20% in a broader market fund for diversification. Rebalance annually so no single holding drifts past ~5% of the total.
Avoid the rookie mistake of owning 15 consumer-staples tickers and calling it "diversified" — they move together. Spread across sectors (industrials like 3M (MMM), healthcare like J&J (JNJ), staples like PG). The Aristocrat list is a starting universe, not a buy-everything list. Our Aristocrat Growth Calculator models how a rising dividend grows your income over time.
The Risks of Chasing the List
Aristocrats are high-quality, but no screen is safe blindly:
- Valuation: A beloved Aristocrat can trade at a premium; buying dear caps your future return.
- Concentration: The index is staples-heavy; a portfolio of Aristocrats can lack tech and healthcare balance.
- Survivorship: Companies get added and removed; today's member can be tomorrow's cutter. The 25-year record is a minimum, not a promise.
Use the list as a quality filter, then apply your own valuation and diversification checks before buying.
A Simple Rebalancing Cadence
Rebalance on a calendar, not a trigger: once a year, on the same date, compare each holding to its target weight. Anything over its band (say +2%) gets trimmed and the proceeds fill the underweight slots. This forces you to sell high and buy low automatically.
Avoid monthly tinkering — it racks up trades and taxes for no real benefit. Annual (or semiannual) is plenty for a dividend-growth portfolio, where the thesis plays out over years, not weeks.
How Many Aristocrats Do You Need?
You do not need all 60+ names. A diversified 15–25 stock sleeve across sectors captures most of the "quality factor" without 60 positions' bookkeeping or overlap. Pair it with an ETF (VIG or SCHD) for breadth and you have the Aristocrat exposure with less concentration.
Owning 50 individual Aristocrats often means heavy staples and utilities overlap — they rise and fall together. Fewer, well-chosen names plus an ETF is the more resilient structure.
Aristocrats vs. Dividend Kings (50+ Years)
Dividend Kings have raised payouts for 50+ consecutive years — an even rarer club (names like Coca-Cola and P&G overlap both lists). The trade-off: more proven, often richer valuation, and slower growth as the base gets large.
Many investors blend a few Kings with a broader Aristocrat ETF rather than committing to one list. The King label signals durability, not a better total return — judge each on valuation and your own growth needs.
Reader Questions About Dividend Aristocrats
25+ consecutive years of dividend increases, membership in the S&P 500, and meeting liquidity rules.
High-quality, but no screen is safe blindly — valuation and concentration still matter (see the risks section).
Beginners often prefer an ETF (VIG/SCHD) for instant diversification; hands-on investors add individual names like KO or PG.
Kings have 50+ years of increases — rarer and often pricier. Many investors blend both rather than choosing one.
15–25 across sectors captures the quality factor without 60+ positions' overlap. Pair with an ETF for breadth.
Aristocrats and the "Quality Factor" in Practice
The real edge of Aristocrats is not the yield — it is the durability. A 25-year raise streak implies pricing power, low debt, and a business that survives recessions. That durability tends to show up as smaller drawdowns in bear markets versus the broader market.
In a 2008-style year, many Aristocrats still cut nothing while the market fell ~50%. For an income investor, avoiding a dividend cut during a downturn is often worth more than an extra 0.5% of starting yield. The list is a screen for that resilience, not just a payout ranking.